Estée Lauder faces legal battles over China’s grey-market sales and Jo Malone trademark
Estée Lauder Company (ELC) has agreed to a US$210 million settlement on a class action lawsuit alleging that the company defrauded shareholders in China, though it still requires approval by US District Judge Arun Subramanian. The suit claims that the ELC was non-transparent about its dependency on grey-market sales in China.
IFF Bets on Origin-Based R&D with New Madagascar Facility for Vanilla Innovation
Flavor and ingredients group IFF has inaugurated a dedicated vanilla research facility in Toamasina, Madagascar, positioning the country’s growing regions as a direct input into its product development process.
Cholesterol Drug May Weaken Ovarian Cancer’s Metastatic Defense
Credit: Steve Gschmeissner/Science Photo LibraryThe accumulation of fluid in the belly, known as ascites, is something that women with advanced ovarian cancer may know all too well. The results of research by a team at Duke University School of Medicine now suggest that, more than causing discomfort, this fluid may protect cancer cells from a form of cell death known as ferroptosis, helping cancer cells survive and spread. The studies also indicated that a decades-old cholesterol-lowering drug, bezafibrate, may be able to disrupt that protection.
Better Balance Returns to Spain’s Festival Circuit for Fifth Year Running
Spanish plant-based brand Better Balance will maintain a presence across several of Spain’s major music festivals in 2026, continuing a run that now spans five consecutive years. The brand is confirmed for Primavera Sound, O Son Do Camiño, PortAmérica, BBK Live, and Río Verbena, with distribution points in both general and VIP areas at each venue.
Korean wellness brand Clöud Café enters Target in latest retail expansion
Clöud Café is making its way into Target right after its Ulta Beauty launch in March. The K-beauty brand is paving the way for a new facet of the space — Korean wellness and ingestible beauty.
Skin and beauty drive growth in Kenvue’s Q1 results ahead of Kimberly-Clark deal
Kenvue has reported robust growth across sales, margins, and earnings in Q1 of 2026, with its Skin Health and Beauty division delivering the strongest performance as the company advances toward its planned acquisition by Kimberly-Clark.
Danone Winds Down US Plant-Based Facility While Doubling Down on Conventional Dairy
Danone is closing its plant-based beverage facility in Bridgeton, New Jersey, with the site scheduled to cease operations on August 4. The closure will affect 114 employees, with layoffs running through November 2, according to a Worker Adjustment and Retraining Notification (WARN) filed with the state.
How HIV-1 Develops Resistance to Broadly Neutralizing Antibodies
One of the most challenging aspects of combatting HIV-1 infection is that the virus continually evades neutralizing antibodies. However, one consequence of this is that a small percentage of people with HIV-1 (1-5%) develop rare, broadly neutralizing antibodies (bNAbs) that can neutralize a large fraction of global HIV-1 isolates. These broadly neutralizing antibodies are among the most promising new long-acting HIV treatments, offering the potential to forego traditional daily dose of antiretroviral drugs. Indeed, a recent trial found that participants who received a single dose of two bNAbs maintained a nearly undetectable viral load for up to 20 weeks, and a third did so for about a year.
RegVelo AI Model Predicts Cell Fate, Tackles Developmental Disorders and Cancer
In a new study published in Cell titled, “ RegVelo: gene-regulatory-informed dynamics of single cells , ” researchers from Stowers Institute of Medical Research have developed a new AI model that connects two areas of single-cell biology that have often remained separate: estimating how cells change over time and inferring the gene regulatory networks controlling those changes.
The Every Company Asks Court to Sanction Onego Bio Over ‘Duplicative’ IP Lawsuits
Finnish startup Onego Bio and its lawyers “should be sanctioned” for filing “improper duplicative litigation based on knowingly false factual allegations”, The Every Company stated in a new motion submitted in a Delaware court.